Literature DB >> 16260299

Culture-independent microbial community analysis with terminal restriction fragment length polymorphism.

Terence L Marsh1.   

Abstract

Terminal restriction fragment length polymorphism is a polymerase chain reaction (PCR)-based technique that has been used to effectively interrogate microbial communities to determine the diversity of both phylogenetic and functional markers. It requires the isolation of community DNA and knowledge of the target sequence. PCR amplification, performed with fluorescently labeled primers, is followed with restriction digestion and size selection on automated sequencing systems. The fluorescent tag identifies the terminal fragment, and the length polymorphism of the terminal fragments reveals a fraction of the phylogenetic diversity within the target sequence. Because the technique has high-throughput capabilities, it performs well in surveys where a large number of samples must be interrogated to ascertain spatial or temporal changes in community structure.

Mesh:

Substances:

Year:  2005        PMID: 16260299     DOI: 10.1016/S0076-6879(05)97018-3

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  9 in total

1.  Prediction of plausible bacterial composition based on terminal restriction fragment length polymorphisms using a Monte Carlo method.

Authors:  Yoshio Nakano; Toru Takeshita; Masaki Yasui; Yoshihisa Yamashita
Journal:  Microb Ecol       Date:  2010-06-24       Impact factor: 4.552

2.  Coupling of denaturing high-performance liquid chromatography and terminal restriction fragment length polymorphism with precise fragment sizing for microbial community profiling and characterization.

Authors:  Christian Penny; Thierry Nadalig; Malek Alioua; Christelle Gruffaz; Stéphane Vuilleumier; Françoise Bringel
Journal:  Appl Environ Microbiol       Date:  2009-11-30       Impact factor: 4.792

3.  T-RFPred: a nucleotide sequence size prediction tool for microbial community description based on terminal-restriction fragment length polymorphism chromatograms.

Authors:  Antonio Fernàndez-Guerra; Alison Buchan; Xiaozhen Mou; Emilio O Casamayor; José M González
Journal:  BMC Microbiol       Date:  2010-10-15       Impact factor: 3.605

4.  T-REX: software for the processing and analysis of T-RFLP data.

Authors:  Steven W Culman; Robert Bukowski; Hugh G Gauch; Hinsby Cadillo-Quiroz; Daniel H Buckley
Journal:  BMC Bioinformatics       Date:  2009-06-06       Impact factor: 3.169

5.  Use of bifidobacterial specific terminal restriction fragment length polymorphisms to complement next generation sequence profiling of infant gut communities.

Authors:  Zachery T Lewis; Nicholas A Bokulich; Karen M Kalanetra; Santiago Ruiz-Moyano; Mark A Underwood; David A Mills
Journal:  Anaerobe       Date:  2012-12-20       Impact factor: 3.331

6.  Changes in cystic fibrosis airway microbial community associated with a severe decline in lung function.

Authors:  Patrizia Paganin; Ersilia Vita Fiscarelli; Vanessa Tuccio; Manuela Chiancianesi; Giovanni Bacci; Patrizia Morelli; Daniela Dolce; Claudia Dalmastri; Alessandra De Alessandri; Vincenzina Lucidi; Giovanni Taccetti; Alessio Mengoni; Annamaria Bevivino
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

Review 7.  The potential link between gut microbiota and IgE-mediated food allergy in early life.

Authors:  John Molloy; Katrina Allen; Fiona Collier; Mimi L K Tang; Alister C Ward; Peter Vuillermin
Journal:  Int J Environ Res Public Health       Date:  2013-12-16       Impact factor: 3.390

8.  Distinct Habitats Select Particular Bacterial Communities in Mangrove Sediments.

Authors:  Lidianne L Rocha; Geórgia B Colares; Vanessa L R Nogueira; Fernanda A Paes; Vânia M M Melo
Journal:  Int J Microbiol       Date:  2016-02-17

9.  Impact of shortened crop rotation of oilseed rape on soil and rhizosphere microbial diversity in relation to yield decline.

Authors:  Sally Hilton; Amanda J Bennett; Gary Keane; Gary D Bending; David Chandler; Ron Stobart; Peter Mills
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.